FDA Approves Omeros' First-In-Class Drug For Rare Transplant Complication

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

Why Omeros (OMER) Is Up 74.0% After First-In-Class TA-TMA Drug Wins FDA Approval

Earlier this month, Omeros Corporation announced that the FDA approved YARTEMLEA (narsoplimab-wuug), the first and only therapy for hematopoietic stem cell transplant-associated thrombotic ...

Omeros surges on FDA nod for transplant therapy (update)

Omeros (OMER) stock in focus as the FDA approves its lead asset as Yartemlea for a complication related to stem cell ...
CBS News

Family of an American held hostage by Hamas urges leaders to "do everything, and we mean everything, to bring them back"

Chief Correspondent and Executive Editor, "Eye on America" Jim Axelrod is the chief correspondent and executive editor for CBS News' "Eye on America" franchise, part of the "CBS Evening News." He also ...
BBC

Omer and Omar: How two 4-year-olds were killed and social media denied it

Omer Siman-Tov and Omar Bilal al-Banna were both killed in the Israel-Gaza war In the opening days of the Israel-Gaza war two small boys, both aged four, were killed. One was Israeli, one Palestinian.
Jewish Journal

On Counting the Omer

It feels like we’ve been counting the Omer for around seven months now. Though the formal Jewish ritual of rattling off seven weeks began the second night of Passover, ever since Oct. 7, the somber ...